Alixia
Targeting the Tumor Ecosystem to address cancer drug resistance.
Our compounds disrupt the metabolic and inflammatory triggers in both cancer and quasi-cancerous cells in the tumor microenvironment. By impacting multiple cell types, we are enabling effective, lasting cancer treatments.
- Website
- alixia.com
- City
- San Francisco
- Country
- United States
- YC batch
- Winter 2022
- Team
- 2 people
- Stage
- Early stage
- AI-native
- No
More Health & bio in San Francisco
Innovaccer$1.3bn
Indian digital healthcare company.
Thatch$1bn
Health benefits. Valued at $1bn (September 2026).
Chan Zuckerberg BiohubLab
Nonprofit research network building virtual cell models.
AthelasHiring
Extensible, Integrated Technology that Simplifies Health Systems
ClipboardHiring
Every shift, Covered.
Benchling
Unlocking the power of biotech with modern software for modern science
Claim this profile
Free and instant: prove you run alixia.com and edit the profile yourself.
- Your logo, office address and founder photos
- The ✓ Verified mark next to Alixia across the site
- Open roles listed on the Hiring board
- A followed link back to your website
A rank card with Alixia's standing on Labspie, or a simple badge. Both link to this profile and update themselves.
